2021
DOI: 10.1016/j.heliyon.2021.e06006
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of TH-Cre knock-in cell lines for detection and specific targeting of stem cell-derived dopaminergic neurons

Abstract: The focal and progressive degeneration of dopaminergic (DA) neurons in ventral midbrain has made Parkinson's disease (PD) a particularly interesting target of cell-based therapies. However, ethical issues and limited tissue availability have so far hindered the widespread use of human fetal tissue in cell-replacement therapy. DA neurons derived from human pluripotent stem cells (hPSCs) offer unprecedented opportunities to access a renewable source of cells suitable for PD therapeutic applications. To better un… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

4
3

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 18 publications
0
6
0
Order By: Relevance
“…Detailed protocols to generate human VM organoids, however, are still lacking. Moreover, modeling human VM in vitro requires the precise balance of patterning factors that lead to the generation of DA neurons exhibiting both mature molecular features and electrophysiological properties, which is not trivial (Nolbrant, Heuer, Parmar, & Kirkeby, 2017;Tiklova et al, 2020;Fiorenzano, Birtele, Wahlestedt, & Parmar, 2021;Fiorenzano et al, 2018).…”
Section: Introductionmentioning
confidence: 99%
“…Detailed protocols to generate human VM organoids, however, are still lacking. Moreover, modeling human VM in vitro requires the precise balance of patterning factors that lead to the generation of DA neurons exhibiting both mature molecular features and electrophysiological properties, which is not trivial (Nolbrant, Heuer, Parmar, & Kirkeby, 2017;Tiklova et al, 2020;Fiorenzano, Birtele, Wahlestedt, & Parmar, 2021;Fiorenzano et al, 2018).…”
Section: Introductionmentioning
confidence: 99%
“…To test whether MISCOs could be used as a human-specific in vitro model to study aspects relevant for Parkinson's disease cell replacement therapy approaches, we injected ventral midbrain progenitors into MISCOs. We used ventral midbrain progenitors with TH-positive cells being genetically labeled with GFP using lentiviral transductions into a TH-Cre reporter line as previously described 53 , and injected 40,000 progenitors into the ventral midbrain tissue 25 (Fig. 5a and Extended Data Fig.…”
Section: Miscos As a Platform For Parkinson's Disease Cell Replacemen...mentioning
confidence: 99%
“…To establish the bioengineered human brain organoid platform, we used a silk scaffold generated via a simple, easily adaptable, and reproducible approach (overall methodological concept presented in Figure 1A). The recombinant spider silk (Widhe et al, 2016) scaffold was biofunctionalized with full length human laminin 111, an important extracellular matrix protein that provides cell-adhesion motifs for stable neuronal adhesion, expansion, and maturation (Kirkeby et al, 2017;Fiorenzano et al, 2021a;Fiorenzano et al, 2021b). To form the scaffolding, air bubbles were introduced into droplets of ice-cold silk protein solution via repeated pipetting (Figures 1B,C).…”
Section: Generation Of Silk Cerebral Organoidsmentioning
confidence: 99%